According to a new report LAMEA Veterinary Point of Care Blood Gas Analyzers Market, published by KBV research, the LAMEA Veterinary Point of Care Blood Gas Analyzers Market would witness market growth of 6.6% CAGR during the forecast period (2018 – 2024).
The Veterinary Clinics market would dominate the LAMEA Veterinary Point of Care Blood Gas Analyzers Market by End User by 2024, growing at a CAGR of 5.7 % during the forecast period. The Veterinary Laboratories market is expected to witness a CAGR of 8% during (2018 - 2024). The Research Laboratories market is expected to witness a CAGR of 6.5% during (2018 - 2024). Additionally, The Other End User market is expected to witness highest CAGR of 8.6% during (2018 - 2024).
The Portable Analyzers market dominated the LAMEA Veterinary Point of Care Blood Gas Analyzers Market by Modality 2017. The Handheld Analyzers market is expected to witness a CAGR of 7.3% during (2018 - 2024).
The Companion Animals market dominated the UAE Veterinary Point of Care Blood Gas Analyzers Market by Animal 2017, and would achieve a market value of $493.1 Thousand by 2024, growing at a CAGR of 5.4 % during the forecast period. The Poultry & Dairy Animals market is expected to witness a CAGR of 5.9% during (2018 - 2024). Additionally, The Livestock Animals market is expected to witness highest CAGR of 7% during (2018 - 2024).
Full Report: https://www.kbvresearch.com/lamea-veterinary-point-of-care-blood-gas-analyzers-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Heska Corporation, Vepalabs (Greencross Ltd.), Nova Biomedical, LifeHealth, LLC., Abaxis, Inc. (Zoetis Inc.), F. Hoffmann-La Roche AG, Bayer AG, Siemens Healthcare, OPTI Medical Systems Inc. (IDEXX Lab) and Radiometer Medical ApS.
LAMEA Veterinary Point of Care Blood Gas Analyzers Market Segmentation
By Animal
By Modality
By End User
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
